NorthStar inks supply deal with Curie Therapeutics

By staff writers

June 7, 2022 -- NorthStar Medical Radioisotopes has inked a long-term supply agreement with Curie Therapeutics for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope.

Under the deal, Curie will gain priority access to NorthStar's no-carrier-added Ac-225 therapeutic radioisotope. Curie will use Ac-225 to support development of targeted radiopharmaceuticals for treating patients with solid tumors, according to the vendors.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking